Order Article Reprints

Dodaran MS, Banihashemi SR, Es-haghi A, Mehrabadi MHF, Nofeli M, Mokarram AR, Mokhberalsafa L, Sadeghi F, Ranjbar A, Ansarifar A, et al. Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial. Vaccines. 2023; 11(2):455. https://doi.org/10.3390/vaccines11020455

Dodaran, Masoud Solaymani, Seyed Reza Banihashemi, Ali Es-haghi, Mohammad Hossein Fallah Mehrabadi, Mojtaba Nofeli, Ali Rezaei Mokarram, Ladan Mokhberalsafa, Fariba Sadeghi, Alireza Ranjbar, Akram Ansarifar, and et al. 2023. "Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial" Vaccines 11, no. 2: 455. https://doi.org/10.3390/vaccines11020455

Dodaran, M. S., Banihashemi, S. R., Es-haghi, A., Mehrabadi, M. H. F., Nofeli, M., Mokarram, A. R., Mokhberalsafa, L., Sadeghi, F., Ranjbar, A., Ansarifar, A., Mohazzab, A., Setarehdan, S. A., Bagheri Amiri, F., Mohseni, V., Hajimoradi, M., Ghahremanzadeh, N., Razzaz, S. H., Masoomi, S., Taghdiri, M., ... Kalantari, S. (2023). Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial. Vaccines, 11(2), 455. https://doi.org/10.3390/vaccines11020455